title: In situ assessment of PI3K and PTEN alterations in mycosis fungoides: correlation with clinicopathological features.
abstract: Deregulated signalling through phosphatidylinositol 3-kinase (PI3K) pathway plays a critical role in tumour initiation and progression. We have already shown that AKT is activated in skin lesions in Mycosis Fungoides (MF) and we herein further investigate the frequency and clinical significance of PTEN and PI3K at the protein and at the DNA level as well as the presence of AKT1 mutations in skin lesions from 50 patients with MF clinical stages I-IV in relation to clinicopathological features. Increased p-AKT expression correlated with poor prognosis in plaques (P = 0.0198), whereas p-AKT was an independent predictor of poor survival in the entire cohort (P = 0.017, HR = 1.012). PTEN cytoplasmic expression was found low or absent in all 77.3% of cases and inversely correlated with advanced clinical stages (P = 0.0744). Molecular analysis showed no AKT1 mutation, no PI3KCA copy number gain, only 1 case with PI3KCA mutation in exon 9 and 3 cases with PTEN mutations (7%) in exons 7, 8 and 5. The latter correlated with disease (P = 0.0253) and progression (P < 0.0001) free survival in tumour stage. Although activation of PI3K/AKT signalling pathway due to PTEN alterations is rarely attributed to abnormalities in PTEN, PI3K, and AKT1 genes, PTEN mutations exert a negative effect on patients' prognosis with tumours.
authors.affiliation: 1st Department of Dermatology, Cutaneous lymphoma Clinic, A Syngros Hospital, University of Athens, Medical School, Athens, Greece; 2d Department of Dermatology, Cutaneous Lymphoma Clinic, ATTIKON University General Hospital, University of Athens, Medical School, Athens, Greece.
authors.forename: Evangelia
authors.initials: E
authors.lastname: Papadavid
authors.forename: Penelope
authors.initials: P
authors.lastname: Korkolopoulou
authors.forename: Georgia
authors.initials: G
authors.lastname: Levidou
authors.forename: Angelica A
authors.initials: AA
authors.lastname: Saetta
authors.forename: Theodora
authors.initials: T
authors.lastname: Papadaki
authors.forename: Marina
authors.initials: M
authors.lastname: Siakantaris
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Nikolaou
authors.forename: Afroditi
authors.initials: A
authors.lastname: Oikonomidi
authors.forename: Ilenia
authors.initials: I
authors.lastname: Chatziandreou
authors.forename: Leonidas
authors.initials: L
authors.lastname: Marinos
authors.forename: Aggeliki
authors.initials: A
authors.lastname: Kolialexi
authors.forename: Alexandros
authors.initials: A
authors.lastname: Stratigos
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Rigopoulos
authors.forename: Amanta
authors.initials: A
authors.lastname: Psyrri
authors.forename: Eftratios
authors.initials: E
authors.lastname: Patsouris
authors.forename: Christina
authors.initials: C
authors.lastname: Antoniou
mesh_terms: D004252:DNA Mutational Analysis; D006801:Humans; D007150:Immunohistochemistry; D009154:Mutation; D009182:Mycosis Fungoides / Q000235:genetics* / Q000378:metabolism*; D009687:Nuclear Proteins / Q000235:genetics; D051059:PTEN Phosphohydrolase / Q000235:genetics* / Q000378:metabolism*; D058539:Phosphatidylinositol 3-Kinase / Q000235:genetics* / Q000378:metabolism*; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics; D015398:Signal Transduction; D012878:Skin Neoplasms / Q000235:genetics* / Q000378:metabolism*; D014157:Transcription Factors / Q000235:genetics
chemical_list: D009687:Nuclear Proteins; C503859:PI3KCA protein, human; D014157:Transcription Factors; D058539:Phosphatidylinositol 3-Kinase; C494918:AKT1 protein, human; D051057:Proto-Oncogene Proteins c-akt; D051059:PTEN Phosphohydrolase; C494929:PTEN protein, human
keywords: PI3K; PTEN; immunohistochemistry; molecular analysis; mycosis fungoides